Cryptogenic organizing pneumonia: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cryptogenic organizing pneumonia}} | {{Cryptogenic organizing pneumonia}} | ||
{{CMG}} | {{CMG}} {{AE}} {{MKK}} | ||
{{SK}} Bronchiolitis obliterans organizing pneumonia; BOOP; COP | {{SK}} Bronchiolitis obliterans organizing pneumonia; BOOP; COP | ||
Line 23: | Line 23: | ||
==[[Cryptogenic organizing pneumonia screening|Screening]]== | ==[[Cryptogenic organizing pneumonia screening|Screening]]== | ||
==[[Cryptogenic organizing pneumonia natural history, complications | ==[[Cryptogenic organizing pneumonia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== |
Latest revision as of 14:18, 28 March 2018
Cryptogenic Organizing Pneumonia Microchapters |
Differentiating Cryptogenic organizing pneumonia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cryptogenic organizing pneumonia On the Web |
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia |
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
Risk calculators and risk factors for Cryptogenic organizing pneumonia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Synonyms and keywords: Bronchiolitis obliterans organizing pneumonia; BOOP; COP
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cryptogenic organizing pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | | Chest X Ray |Electrocardiogram | Echocardiography and Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies